Greta Adorni is a lead scientist at Chiesi Farmaceutici SpA. She holds a master’s degree in Pharmaceutical Chemistry and Technology (2015) and a Ph.D. in Drug Sciences, Biomolecules and Health Products (2020) from the University of Parma, Italy. Her doctoral research focused on the development of an inhalation powder to be administered as DPI for the treatment of cystic fibrosis patients. Greta joined Chiesi in 2023 and has since then been supporting late phase projects for a worldwide market authorization.
